Director Suliman Shehnaaz was granted 7,751 shares and sold $144,189 worth of shares (5,740 units at $25.12), increasing direct ownership by 8% to 27,951 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

RARE· Ultragenyx Pharmaceutical Inc.

Health Care

Original source

Director Suliman Shehnaaz was granted 7,751 shares and sold $144,189 worth of shares (5,740 units at $25.12), increasing direct ownership by 8% to 27,951 units (SEC Form 4) | Quantisnow